Skip to content

Surgipro SMHP-01Recalls & reported problems

Covidien LP · Mesh Hernia Patch · Class 2 · Implant

All models of Surgipro (62)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10884521176003), received between May 18, 2021 and Jan 27, 2026 — classified as 2 injuries.

The most frequently reported specific device problem is “Migration or Expulsion of Device” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 1 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2
  • Migration or Expulsion of Device1
  • Patient Device Interaction Problem1

Patient problems

  • Hernia2
  • Pain2
  • Unspecified Tissue Injury2
  • Abdominal Distention1
  • Abdominal Pain1
  • Abscess1
  • Adhesion(s)1
  • Ascites1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryJan 27, 2026Adverse Event Without Identified Device or Use Problem

    THE PATIENT'S ATTORNEY ALLEGED A DEFICIENCY AGAINST THE DEVICE. THE PRODUCT WAS USED FOR THERAPEUTIC TREATMENT OF A RIGHT INGUINAL HERNIA. IT WAS REPORTED THAT AFTER IMPLANT, THE PATIENT EXPERIENCED EMOTIONAL DISTRESS, PAIN, RECURRENCE, SUFFERING. POST-OPERATIVE PATIENT TREATMENT INCLUDED REVISION SURGERY, MESH REMOVAL, NEURECTOMY, HERNIA REPAIR WITH MESH.

    Patient problems: Distress; Hernia; Pain; Unspecified Tissue Injury

    MAUDE report 24192146 ↗
  • InjuryMay 18, 2021Migration or Expulsion of Device; Adverse Event Without Identified Device or Use Problem; Patient Device Interaction Problem; Migration or Expulsion of Device; Adverse Event Without Identified Device or Use Problem; Patient Device Interaction Problem

    THE PATIENT¿S ATTORNEY ALLEGED A DEFICIENCY AGAINST THE DEVICE. THE PRODUCT WAS USED FOR THERAPEUTIC TREATMENT OF A RIGHT INGUINAL HERNIA. IT WAS REPORTED THAT AFTER IMPLANT, THE PATIENT EXPERIENCED RECURRENCE, SMALL BOWEL OBSTRUCTION, MESH FOLDED/ROLLED/WADDED UP, ABSCESS, SCARRING, ADHESIONS, FISTULA, INFLAMMATION, OPEN DRAINING WOUND, PAIN, HEMATOMA, SEROMA, ABDOMINAL PUS SAC, NECROSIS, DRAINAGE, BLEEDING, AND PERFORATION. POST-OPERATIVE PATIENT TREATMENT INCLUDED REVISION SURGERY, INCISION AND DRAINAGE, HERNIA REPAIR WITH NEW MESH, UMBILICUS AND SURROUNDING SKIN EXCISED, AND MEDICATION.

    Patient problems: Abdominal Distention; Abdominal Pain; Abscess; Adhesion(s); Ascites; Decreased Appetite; Fever; Fistula; Fluid Discharge; Hematoma; Hemorrhage/Blood Loss/Bleeding; Hernia; Impaired Healing; Inflammation; Necrosis; Obstruction/Occlusion; Pain; Perforation; Purulent Discharge; Scar Tissue; Seroma; Swelling/ Edema; Ulcer; Unspecified Tissue Injury

    MAUDE report 11845959 ↗

Other Mesh, surgical, polymeric devices

All Mesh, surgical, polymeric devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page